thetaOwl

MSTR

Strategy IncClose $148.94EOD only
Max Pain
$132.00
Next expiry Apr 17, 2026
Expected Move
±$4.83
3.2% from close
Price Gap
-16.94
Distance to max pain
IV Rank
100
High premium
P/C OI
0.83
Slightly call-heavy
Consensus
5.0/10
Consensus signal
Published snapshot: Apr 16, 2026 close
End-of-day snapshot

This page reflects MSTR options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Apr 16, 2026 close
MSTR Directional Report
Analysis based on market close April 17, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Outlook

Modestly bullish: dealers are net long gamma concentrated around current/upper strikes, supporting price stickiness and a drift higher; downside risk remains if broad-market vol spikes.

Confidence:
8 / 10
Positive GEX and sustained bullish flow concentrated at-and-above spot; IV rich but not systemic; spot above short-term midpoint.
Supports: Dealer GEX +78.6M concentrated near spot/upper strikes; sustained buy flow; DEX long shares
Conflicts: Historical max-pain sits lower (mid-130s) which could pull price if flows reverse; elevated IV can widen two-way moves
📌Dealers long gamma around current/upper strikes — favors stickiness near spot
⚠️Max-pain lower strikes and high IV mean a reversal in flow could rapidly bias downside

Regime Classification

Vol Regime
High
IV elevated vs MSTR history but aligns with VIX~17; premium rich for short-dated expiries.
Gamma Regime
Pinning
Pinning: dealers long gamma concentrated at and slightly above spot (upper weekly strikes), encouraging limited downside and upward drift; not aligned with older max-pain bands.
Flow Regime
Bullish
Net bullish option and equity flow into calls at/above spot; dealer hedging buys underlying into strength.
Spot vs Max Pain
Above
Spot sits well above historical max-pain (mid-130s) because recent flow shifted open interest and gamma toward higher strikes; this creates a temporary conflict between structural max-pain and live gamma pinning.
Thesis duration: Multi-week — Persistent bullish flow and concentrated positive GEX around spot/upper strikes sustain bias beyond single events.

Price Range Forecast

Next 1 week
$151.70$181.35
Pinning around current/upper strikes; break above $181 extends momentum.
Next 2 weeks
$146.15$186.90
Multi-week bias but susceptible to IV-driven pullbacks; watch $146 support / $187 resistance.

Key Levels

Max pain pins: $132 (2026-04-17); $140 (2026-04-24); $133 (2026-05-01)
EM guardrails: 1w $151.70/$181.35
Support: $146.15
Resistance: $186.90
Structural: Max pain: mid-130s (historical OI). 1w guardrails $151.70 / $181.35. Structural support ~$146.15; resistance ~$186.90.

Dealer Positioning (GEX/DEX)

GEX: $+78.6M

DEX: +71.6M shares

Gamma flip: N/A

NTM gamma: GEX +$78.6M with concentration of long-gamma/delta exposure at and above spot; dealers buy underlying into strength, promoting stickiness near present levels.

IV Analysis

IV vs VIX: IV rich vs MSTR history but roughly in line with VIX~17; elevated IV makes selling premium attractive but risky if realized vol jumps.

Term structure: Front-month elevated with kinks at weekly expiries and concentrations around upper-week strikes.

Skew: Put skew exists lower; actionable: sell elevated front-week premium or structure defined-risk credit spreads targeting pin range.

Flow Analysis

Net premium: Estimated net premium on printed volume ~ $26M (sum vols 263,967 × assumed ~$1 premium × 100 multiplier). Without fill-level prices this is approximate; does not support a $480M claim.

Directional prints: 20.7 call 170 OTM 2026-04-17 — 118,516 vol vs 6,266 OI — large short-dated call flow; likely mix of buy- and sell-side activity (aggressive accumulation possible) suggesting call-skew but not definitive directional conviction. 39.8 call 175 OTM 2026-04-17 — 73,777 vol vs 2,684 OI — concentrated short-dated calls reinforcing call skew; could be directional buys or covered/hedged sales, interpret cautiously.

Unusual: 15.6 put 165 OTM 2026-04-17 — 49,150 vol vs 1,496 OI and low IV — significant put activity consistent with short-put or put selling interest, which would be mildly bullish if sells. 30.3 put 170 ITM 2026-04-17 — 22,524 vol vs 514 OI (vol/oi ~43.8) — one-sided block-sized prints; could be institutional hedges or directional buys/sells; interpret as elevated activity, not definitive pinning.

Risks & Catalysts

!SPX/QQQ-led risk-off spike lifting realized vol
!Flow reversal shifting open interest back toward lower strikes (max-pain)
!Idiosyncratic MSTR news (earnings/crypto link) causing rapid IV repricing

Strategy Viability

StrategyEdgeBest SetupPrimary Risk
Bull call spreadModerate-Strong
Buy 2026-05-15 $165.00/$175.00 call spread
Why now: Capture modest drift higher while limiting cost and vega exposure; use expirations after earnings for follow-through.
IV repricing on idiosyncratic news or broad-market vol spike can widen spreads.
Put credit spreadModerate
Sell 2026-05-15 $155.00/$125.00 put spread
Why now: Premium-rich near strikes and dealer gamma support around current/upper strikes make short lower-put premium attractive; defined wing hedges tail risk.
Sudden downside vol spike or flow reversal could stress the short leg.
Bullish risk reversalModerate-Strong
Buy 2026-06-18 $170.00 call / sell 2026-06-18 $158.00 put
Why now: Sell nearer-dated put premium (supports carry) and buy back-month call to capture post-earnings drift/convexity while limiting cash exposure.
Short put can suffer on idiosyncratic downside or market-wide vol spike; calendar mismatch vega risk.

Top Plays

#1
May bull-call 165/175 (5/15)
Buy 2026-05-15 $165.00/$175.00 call spread
Buy 165C / sell 175C (10-wide) to cap cost and gamma; assume net debit ≈$6.5 → max profit $3.5 (10−6.5) ≈54% ROI if spread fills, breakeven ≈171.5.
Why this play: Targets modest post-earnings drift with low vega: IV ~48% → net vega ≈ -0.8; 165C Δ≈+0.42, 175C Δ≈+0.17; estimated prob. underlying ≥165 by expiry ≈35%; estimated max return ≈+25–30% on debit.
Debit: $3.62-$4.43
Max loss: $4.43
BE: $169.43
Mgmt: Enter with target debit ≤$6.5; close or roll if underlying >175 or IV drops >8 vol points; cut if price <146.15 (invalidates bias).
Trader wanting defined-risk bullish exposure with limited vega and controlled capital.
#2
Jun risk-reversal (buy 170C / sell 158P, 6/18)
Buy 2026-06-18 $170.00 call / sell 2026-06-18 $158.00 put
Buy 170C / sell 158P to express convex upside funded by put premium; initial net debit ≈$0.50–$1 (near flat), one-sided upside with funded cost and ~+2.8 vega exposure.
Why this play: Leverages directional upside while largely funded: call Δ≈+0.38, put Δ≈−0.28; net vega ≈+2.8; prob. 170C ITM ≈28%, 158P assignment prob. ≈12%; scenario P/L: +100%+ if stock rallies >12% by expiry, downside loss concentrated if gap down.
Debit: $3.60-$4.40
Max loss: $158.00
BE: $158.00
Mgmt: Trim calls after >20% move up; monitor put-side delta and close/sell hedge if put Δ exceeds −0.45 or IV spikes >10 vol pts; cut at invalidation 146.15.
Aggressive bullish traders seeking leverage with low upfront debit and tolerance for assignment risk.
#3
May put-credit 155/125 (5/15)
Sell 2026-05-15 $155.00/$125.00 put spread
Sell 155/125 put spread to collect ~ $2.50; probability spread expires worthless ≈70% given current skew/IV (~50%); favorable theta but large asymmetric defined loss if breached.
Why this play: Highest premium collected: collect ≈$2.50 credit on 30-wide → premium ≈8.3% of width; breakeven stock ≈152.5; max loss = width − credit = $27.50 (~11.7× premium).
Credit: $6.09-$7.44
Max loss: $22.56
BE: $147.56
Mgmt: Keep size small; hedge or roll if price <155 (approach breakeven 152.5); stop if price <146.15 or if spread MV >50% of max loss.
Income-focused traders accepting large defined wing risk for steady premium.

Watchlist Triggers

Entry Triggers
IFIF MSTR best-fill for 2026-05-15 165/175 call spread ≤ $4.43 AND price >146.15THEN buy 2 contracts 2026-05-15 165/175 call spread (target fill ≤ $4.43); take profit at 50% gain or close if underlying >175; stop-loss: close if MSTR price <146.15; close if IV drops >8 vol pts from entry.
IFIF net cost to buy 2026-06-18 170C and sell 2026-06-18 158P ≤ $4.40 AND price >146.15THEN establish bullish risk-reversal: buy 3 contracts 170C / sell 3 contracts 158P (net debit ≤ $4.40); trim half of calls after underlying ↑>20% from entry; close or delta-hedge sold puts if put Δ ≤ -0.45 or IV rises >10 vol pts; stop-loss: close if MSTR price <146.15.
Adjustment Triggers
ADJIF MSTR price <155 OR sold 2026-05-15 155/125 put spread MTM loss >50% of max loss OR price <146.15THEN for existing 155/125 put spreads (typical size 4 contracts): if price <155 or MTM loss>50% roll 155/125 → 155/120 (widen lower leg to 120) for up to 4 contracts only if roll cost ≤1.5× premium received; otherwise close remaining contracts outright. If price <146.15, close all put-credit positions immediately.

Tactical Summary

Modestly bullish multi-week bias. Position sizing: call spreads = 2 contracts, risk-reversal = 3 contracts, put-credit = max 4 contracts. Per-trade max portfolio risk ~1% (use position size to cap). Strict stops: close puts/credits at 146.15 breach; use provided roll targets (155/120) when adjusting.

Read the Directional analysis for MSTR for 2026-04-17. Each report is a market-close snapshot with regime read, key levels, and strategy context that translates options positioning into an actionable setup.